First Trust Capital Management’s Celularity CELU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-33,276
Closed -$3.35M 226
2021
Q1
$3.35M Buy
33,276
+14,204
+74% +$1.46M 0.66% 20
2020
Q4
$2.1M Sell
19,072
-11,641
-38% -$1.24M 0.59% 45
2020
Q3
$3.23M Buy
30,713
+26,065
+561% +$2.7M 0.87% 23
2020
Q2
$474K Buy
+4,648
New +$461K 0.15% 41

Other funds holding CELU

First Trust Capital Management's CELU Position: Q2 2021 in Review

First Trust Capital Management sold out of Celularity (CELU) in Q2 2021, closing a stake of 33,276 shares — an estimated $3.35M sold.

First Trust Capital Management first reported a position in CELU in Q2 2020 and held it in 4 quarters. The position peaked at $3.35M in Q1 2021. 33 funds tracked by Wall St. Rank hold CELU as of Q2 2021.

  • First Trust Capital Management reported no remaining Celularity position as of Q2 2021 after selling out during the quarter.
  • First Trust Capital Management sold 33,276 Celularity shares in Q2 2021, an estimated $3.35M.
  • First Trust Capital Management first reported a position in Celularity in Q2 2020 and held it in 4 quarters.
  • First Trust Capital Management's Celularity position peaked at $3.35M in Q1 2021.
  • 33 funds tracked by Wall St. Rank held Celularity as of Q2 2021.

Based on First Trust Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.